These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Alterations in expression of dopamine receptors and neuropeptides in the striatum of GTP cyclohydrolase-deficient mice. Zeng BY; Heales SJ; Canevari L; Rose S; Jenner P Exp Neurol; 2004 Dec; 190(2):515-24. PubMed ID: 15530890 [TBL] [Abstract][Full Text] [Related]
12. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337 [TBL] [Abstract][Full Text] [Related]
14. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Furukawa Y; Nygaard TG; Gütlich M; Rajput AH; Pifl C; DiStefano L; Chang LJ; Price K; Shimadzu M; Hornykiewicz O; Haycock JW; Kish SJ Neurology; 1999 Sep; 53(5):1032-41. PubMed ID: 10496263 [TBL] [Abstract][Full Text] [Related]
15. A clue to the pathogenesis of dopa-responsive dystonia. Furukawa Y; Mizuno Y; Nishi K; Narabayashi H Ann Neurol; 1995 Jan; 37(1):139-40. PubMed ID: 7818251 [No Abstract] [Full Text] [Related]
16. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA. Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311 [TBL] [Abstract][Full Text] [Related]
17. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra. Cole DG; Growdon JH; DiFiglia M Exp Neurol; 1993 Apr; 120(2):223-32. PubMed ID: 8491280 [TBL] [Abstract][Full Text] [Related]
18. A new knock-in mouse model of l-DOPA-responsive dystonia. Rose SJ; Yu XY; Heinzer AK; Harrast P; Fan X; Raike RS; Thompson VB; Pare JF; Weinshenker D; Smith Y; Jinnah HA; Hess EJ Brain; 2015 Oct; 138(Pt 10):2987-3002. PubMed ID: 26220941 [TBL] [Abstract][Full Text] [Related]
19. A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets. Iravani MM; Syed E; Jackson MJ; Johnston LC; Smith LA; Jenner P Eur J Neurosci; 2005 Feb; 21(4):841-54. PubMed ID: 15787691 [TBL] [Abstract][Full Text] [Related]
20. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease. Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]